LIPO

$0.00+0.00%visit website

LIPELLA PHARMACEUTICALS INC.

Market Cap

$2,772.502

Live price × SEC shares (Nov 13, 2025)

Sector

Health Care

Industry

Biotechnology

Beta (raw)

1.15

46mo monthly vs SPY

P/E (TTM)

N/M

TTM to Sep 2025 · negative earnings

No 10-Q/10-K since Nov 14, 2025

P/S (TTM)

0.0

TTM to Sep 2025 · revenue

No 10-Q/10-K since Nov 14, 2025

P/B

0.0

Mkt cap / shareholders' equity

No 10-Q/10-K since Nov 14, 2025

EV/EBITDA (TTM)

—

EV / TTM EBITDA

No 10-Q/10-K since Nov 14, 2025

Loading…

Financial Statements

USD thousands	Q4 FY2024 Dec 31, 2024	Q1 FY2025 Mar 31, 2025	Q2 FY2025 Jun 30, 2025	Q3 FY2025 Sep 30, 2025	TTM Sep 30, 2025
Revenue	174	129	87	0	390
Research & development	1,062	993	792	721	3,568
Operating income	(1,451)	(1,328)	(1,357)	(1,274)	(5,410)
Pretax income	(1,442)	(1,307)	(1,327)	(1,254)	(5,330)
Net income	(1,442)	(1,307)	(1,327)	(1,254)	(5,330)
EPS (basic) ($)		(0.64)	(0.31)	(0.28)	—
EPS (diluted) ($)		(0.64)	(0.31)	(0.28)	—
Weighted avg. shares (basic)		2,057	4,305	4,549
Weighted avg. shares (diluted)		2,057	4,305	4,549

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Nov 14, 2025, period ended Sep 30, 2025. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 11 more quarters, back to Mar 2022, with Tormere Pro.

Corporate Events (8-K)

3 filings in 12 months · 2 with priority itemsFull history →

Filed	Items	Filing
Jul 15, 2026 accepted 10:38 AM ET	1.03Bankruptcy	Document SEC ↗
Mar 31, 2026 accepted 8:23 PM ET	1.03Bankruptcy	Document SEC ↗
Feb 4, 2026 accepted 4:19 PM ET	5.02Officer / director change	Document SEC ↗
Oct 21, 2025 accepted 4:18 PM ET	5.02Officer / director change	Document SEC ↗
Oct 9, 2025 accepted 5:00 PM ET	5.02Officer / director change	Document SEC ↗
Sep 18, 2025 accepted 8:01 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Jun 25, 2025 accepted 3:14 PM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Jun 20, 2025 accepted 4:02 PM ET	3.01Delisting notice7.01Reg FD disclosure	Document SEC ↗
Jun 16, 2025 accepted 4:25 PM ET	8.01Other events	Document SEC ↗
May 16, 2025 accepted 4:05 PM ET	3.01Delisting notice	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

—

of daily vol

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

No Form 4 transactions on record.

Recent News

National Advertising Division Recommends Lipo Flavonoid Discontinue or Modify Certain Claims for Earwax Cleansing Kit & Aid Drops

Yahoo Finance · 2026-09-24

Biotech Stocks: The New Drugs That Could Fuel Big Gains

Barron's · 2026-08-07

Lipella Pharmaceuticals files for bankruptcy protection four years after going public

Yahoo Finance · 2026-04-02

Lipella Pharmaceuticals Inc. Files Voluntary Petitions for Relief Under Chapter 11

Yahoo Finance · 2026-03-31

New therapies on the way to lower Lp(a), a cardiovascular risk factor

Managed Healthcare Executive · 2026-01-12

Taking Vitamins? Here’s Why They Might Not Be Doing Their Job (Yet)

The Everygirl · 2025-11-12

Anesthesiologist Who Danced While Patient Got Lipo Cleared in Lawsuit

Business Insider · 2023-08-01

Lipella Pharmaceuticals Inc. (LIPO) Stock Price, News, Quote & History

Yahoo! Finance Canada · 2023-01-09

Lipella Pharmaceuticals (LIPO) Stock Price, News & Analysis $LIPO

MarketBeat · 2022-12-21

Lululemon Founder Chip Wilson Sells Millions of Dollars of Stock

Barron's · 2019-09-21

Informational purposes only, not investment advice.

Corporate Events (8-K)

3 filings in 12 months · 2 with priority itemsFull history →

Filed	Items	Filing
Jul 15, 2026 accepted 10:38 AM ET	1.03Bankruptcy	Document SEC ↗
Mar 31, 2026 accepted 8:23 PM ET	1.03Bankruptcy	Document SEC ↗
Feb 4, 2026 accepted 4:19 PM ET	5.02Officer / director change	Document SEC ↗
Oct 21, 2025 accepted 4:18 PM ET	5.02Officer / director change	Document SEC ↗
Oct 9, 2025 accepted 5:00 PM ET	5.02Officer / director change	Document SEC ↗
Sep 18, 2025 accepted 8:01 AM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Jun 25, 2025 accepted 3:14 PM ET	7.01Reg FD disclosure8.01Other events	Document SEC ↗
Jun 20, 2025 accepted 4:02 PM ET	3.01Delisting notice7.01Reg FD disclosure	Document SEC ↗
Jun 16, 2025 accepted 4:25 PM ET	8.01Other events	Document SEC ↗
May 16, 2025 accepted 4:05 PM ET	3.01Delisting notice	Document SEC ↗

LIPO

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

LIPELLA PHARMACEUTICALS INC. (LIPO)

Factor Profile

Corporate Events (8-K)